A new breast cancer drug is being tested in Manchester, that could be a lifeline to women with the most aggressive form of the disease.
The drug, known as T-DM1, is designed to slow the progress of The treatment increases the survival time of some patients by almost six months.
It also reduces side effects such as hair loss, and gives sufferers a better quality of life
More top news
Monday proves a brighter, colder day than Sunday. One or two showers pushing in and turning wintry over the hills inland
Just when you thought we had a reprieve from the colder weather, it looks set to turn colder again on Monday, with snow in prospect midweek
City manager Manuel Pellegrini tried to shift focus to next week's critical clash with Chelsea after his side's FA Cup humbling.